Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors.

Nature
Xiaocong YuJames E Crowe

Abstract

Investigation of the human antibody response to influenza virus infection has been largely limited to serology, with relatively little analysis at the molecular level. The 1918 H1N1 influenza virus pandemic was the most severe of the modern era. Recent work has recovered the gene sequences of this unusual strain, so that the 1918 pandemic virus could be reconstituted to display its unique virulence phenotypes. However, little is known about adaptive immunity to this virus. We took advantage of the 1918 virus sequencing and the resultant production of recombinant 1918 haemagglutinin (HA) protein antigen to characterize at the clonal level neutralizing antibodies induced by natural exposure of survivors to the 1918 pandemic virus. Here we show that of the 32 individuals tested that were born in or before 1915, each showed seroreactivity with the 1918 virus, nearly 90 years after the pandemic. Seven of the eight donor samples tested had circulating B cells that secreted antibodies that bound the 1918 HA. We isolated B cells from subjects and generated five monoclonal antibodies that showed potent neutralizing activity against 1918 virus from three separate donors. These antibodies also cross-reacted with the genetically similar HA...Continue Reading

References

Jul 10, 1997·Nature·R A ManzA Radbruch
Apr 7, 1998·Immunity·M K SlifkaR Ahmed
Dec 11, 1999·Nucleic Acids Research·M RuizM P Lefranc
Jan 10, 2002·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·G G Brownlee, E Fodor
Mar 5, 2002·Bulletin of the History of Medicine·Niall P A S Johnson, Juergen Mueller
Oct 9, 2002·Proceedings of the National Academy of Sciences of the United States of America·Terrence M TumpeyChristopher F Basler
Dec 14, 2002·Science·Nadia L BernasconiAntonio Lanzavecchia
Aug 20, 2003·Nature Medicine·Erika HammarlundMark K Slifka
Nov 11, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Shane CrottyRafi Ahmed
Oct 7, 2005·Nature·Jeffery K TaubenbergerThomas G Fanning
Oct 8, 2005·Science·Terrence M TumpeyAdolfo García-Sastre
Jul 11, 2006·Immunological Reviews·Ian J AmannaShane Crotty
Aug 31, 2006·Annals of Internal Medicine·Thomas C LukeStephen L Hoffman
Nov 9, 2007·The New England Journal of Medicine·Ian J AmannaMark K Slifka
Jun 3, 2008·Journal of Immunological Methods·Xiaocong YuJames E Crowe

❮ Previous
Next ❯

Citations

Nov 13, 2013·Immunology and Cell Biology·Michelle A Linterman
May 28, 2013·Archivum Immunologiae Et Therapiae Experimentalis·K Kai McKinstryTara M Strutt
Apr 7, 2012·Cellular and Molecular Life Sciences : CMLS·Claude-Agnès ReynaudJean-Claude Weill
Mar 10, 2010·Immunogenetics·Nima SalimiAlessandro Sette
May 11, 2013·Immunology Letters·Federica CapolunghiRita Carsetti
Mar 25, 2009·Immunology and Cell Biology·Lorena E Brown, Anne Kelso
Oct 27, 2010·Nature Communications·Rafael A MedinaAdolfo García-Sastre
May 19, 2009·Nature Immunology·Peter D Kwong, Ian A Wilson
Dec 20, 2013·Nature Immunology·Florian Krammer, Peter Palese
Feb 28, 2009·Nature Protocols·Kenneth SmithPatrick C Wilson
Sep 26, 2012·Nature Reviews. Immunology·Patrick C Wilson, Sarah F Andrews
Feb 10, 2012·Lab on a Chip·Mira T GuoDavid A Weitz
Jul 1, 2009·The New England Journal of Medicine·Shanta M Zimmer, Donald S Burke
Mar 4, 2009·Proceedings of the National Academy of Sciences of the United States of America·Mikhail PopkovCarlos F Barbas
May 11, 2013·Science·James E Crowe
Feb 8, 2013·Science Translational Medicine·Ning JiangStephen R Quake
Jun 10, 2011·Clinical and Vaccine Immunology : CVI·Eeva BrobergAndrew Amato-Gauci
Dec 28, 2012·Journal of Virology·Lisa C LindesmithRalph S Baric
Mar 30, 2012·Journal of Virology·Jens C KrauseJames E Crowe
Sep 13, 2012·MBio·Jeffery K TaubenbergerIan A Wilson
Sep 4, 2013·The Journal of Clinical Investigation·Natalie J ThornburgJames E Crowe
Feb 4, 2011·BMC Infectious Diseases·Yoshinari KimuraHiroshi Suzuki
Sep 26, 2008·Immunity & Ageing : I & a·Evelyna DerhovanessianGraham Pawelec
Feb 26, 2010·Immunity & Ageing : I & a·Eric J YagerMarcia A Blackman
Jun 16, 2010·Immunity & Ageing : I & a·Joseph Ongrádi, Valéria Kövesdi
Mar 1, 2012·Journal of Leukocyte Biology·Christine M Oshansky, Paul G Thomas

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.